WRL 105 STRAIN (H3N2) LIVE ATTENUATED INFLUENZA VACCINE: ACCEPTABILITY, REACTIVITY, AND ANTIBODY RESPONSE IN NORMAL, BRONCHITIC, AND GERIATRIC VOLUNTEERS
- 31 May 1976
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 307 (7973) , 1309-1311
- https://doi.org/10.1016/s0140-6736(76)92648-9
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- New Live Attenuated Influenza A/England/42/72 (H3N2) Vaccine (Alice): Reactogenicity, Immunogenicity, and Protection EfficacyThe Journal of Infectious Diseases, 1975
- RECOMBINANT WRL 105 STRAIN LIVE ATTENUATED INFLUENZA VACCINE: Immunogenicity, Reactivity, and TransmissibilityThe Lancet, 1975
- INFLUENZA VACCINATION AND MORTALITY FROM BRONCHOPNEUMONIA IN THE ELDERLYThe Lancet, 1975
- An Attenuated Influenza Virus Vaccine: Reactogenicity, Transmissibility, Immunogenicity, and Protective EfficacyThe Journal of Infectious Diseases, 1974
- Immune Response to Vaccination with a Live Influenza Virus (H 3 N 2 ) Vaccine (“Ann” Strain)Infection and Immunity, 1973
- Antibody responses and resistance to challenge in volunteers vaccinated with live attenuated, detergent split and oil adjuvant A2/Hong Kong/68 (H3N2) influenza vaccines A report to the Medical Research Council Committee on Influenza and other Respiratory Virus VaccinesEpidemiology and Infection, 1972
- Prolonged effects of viral infections of the upper respiratory tract upon small airwaysThe American Journal of Medicine, 1972
- A COMPARISON OF LIVE AND KILLED INFLUENZA-VIRUS VACCINES: Report to the Medical Research Council's Committee on Influenza and other Respiratory Virus VaccinesThe Lancet, 1968